Current status of immunotherapy for the treatment of biliary tract cancer

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

Targeting cancer stem cells via dendritic-cell vaccination

Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy

Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review

Dendritic cell-based immunotherapy in mesothelioma